1.
J Pediatr
; 131(5): 656-7, 1997 Nov.
Article
in English
| MEDLINE
| ID: mdl-9403640
Subject(s)
Neuroblastoma/genetics , Neurofibromatosis 1/genetics , Catecholamines/urine , Child , Child, Preschool , Chromosome Aberrations/genetics , Chromosome Disorders , Genes, Tumor Suppressor/genetics , Genetic Linkage/genetics , Homozygote , Humans , Neuroblastoma/complications , Neurofibromatosis 1/complications , Phenotype , Point Mutation/genetics , Turner Syndrome/complications , X Chromosome
2.
J Pediatr
; 126(2): 269-71, 1995 Feb.
Article
in English
| MEDLINE
| ID: mdl-7844677
ABSTRACT
We investigated the loss of detectable antibody directed against the hepatitis B surface antigen after immunization with hepatitis B vaccine in 55 patients who were seronegative for the human immunodeficiency virus and had hemophilia. Twenty percent of patients lost detectable antibody at a mean of 4.6 years after completion of immunization. Monitoring of hepatitis B serostatus or routine revaccination may be necessary.